Skip to Main Content

Select Funding Opportunities

Click here to visit the NCI grant site.

Use your device's search function to find a specific disease or funding source.


Funding

The Vera and Joseph Dresner Foundation MDS Research Fund
The fund will facilitate the advancement of innovative basic science, translational or clinical research to advance the understanding and treatment of Myelodysplastic Syndromes (MDS) and related blood disorders (such as MDS/myeloproliferative neoplasms (MPN) overlap syndromes, secondary acute myeloid leukemia following MDS, idiopathic cytopenia of undetermined significance (ICUS), or clonal hematopoiesis of indeterminate potential (CHIP).

The foundation will consider proposals from individuals at university, college, hospital, or laboratory institutions for support of research in MDS or related disorders in two types:
- Early Career Awards
- Established Investigator Awards

Letter of Intent (LOI) Deadline: LOIs are accepted on a rolling basis.
Learn More>>


Launching soon: ASCI Emerging-Generation Awards

These awards recognize post-MD, pre-career physician-scientists who are meaningfully engaged in immersive research, giving them access to the Joint Meeting and longitudinal programming similar to the YPSA program. Entry into the ASCI network at this stage is intended to provide peer support and inspiration to stay the course into a physician-scientist faculty appointment.

Look for E-Gen Awards nominations to open in late October. Contact programs@the-asci.org for more information.


BMSF Clinical Investigator Pipeline Program

This Program was established in order to build the pipeline of community oriented clinical trialists of diverse backgrounds who are committed to increasing diversity, equity and inclusion in clinical trials. This will be a 6-week summer externship program for 250 underrepresented medical students, and with hands-on community-oriented clinical trial experience in underserved communities.

Application Deadline: January 28, 2022


2022 Young Investigator Award (YIA) for Invasive Lobular Carcinoma Research

The 2022 Conquer Cancer - Lobular Breast Cancer Alliance Young Investigator Award (YIA) for Invasive Lobular Carcinoma Research provides funding to promising investigators to encourage and promote quality research in clinical oncology with a focus on invasive lobular carcinoma (ILC). ILC is a challenging and understudied form of breast cancer. Questions about the competition can be directed to grants@conquer.org

Application Deadline: January 31, 2022


Leslie Warner Postdoctoral Fellowships for Cancer Research

The Fellowships will support early-stage promising trainees that are conducting innovative basic, translational, clinical, or population-based cancer research with a Yale Cancer Center member. Relevance of proposed research to our catchment area priorities is also encouraged. Candidates may have up to one year of postdoctoral experience from the time of application.

Internal Deadline: February 1, 2022

Leukemia Research Foundation Grant

The application process for the 2022-2023 funding cycle has begun! Grants of up to $100K are available to new investigators -- researchers within seven years of their first independent faculty-level position. Research projects must focus on a blood cancer (leukemia, lymphoma, myeloma, or MDS).

Letter of Intent Due: February 4, 2022


Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01, R21)

The purpose of this FOA is to support basic research that elucidates mechanisms by which the human microbiome inhibits or enhances anti-tumor immune responses, and to identify potential novel molecular targets for cancer prevention strategies.

Application Deadline: February 5, 2022


Pediatric Oncology Student Training (POST) Program

As part of the Alex’s Lemonade Stand Foundation (ALSF), the POST Program is designed for undergraduate, graduate, and medical students who have an interest in pediatric oncology research and would like to experience the field firsthand. Students train with a pediatric oncology research mentor. Students may join a research project underway in a mentor’s lab or begin an original investigation with the mentor.

Application Deadline: February 21, 2022


Bladder Cancer Advocacy Network (BCAN) Early Career Investigator Awards

Young Investigator Award 2022: This award is for outstanding early-career scientists and clinical cancer research investigators with a demonstrated commitment to improving the understanding and treatment of bladder cancer and/or upper tract urothelial cancer research. Learn more about the BCAN YIA>>
2022 Patient-Centered Clinical Research Young Investigator Award: PCCYIA is for early-career scientists and clinical care researchers investigating transformational patient-oriented clinical bladder cancer

Application Deadlines: February 22, 2022

International Lung Cancer Foundation Research Grants

Adequate research funding is key to furthering developments in lung cancer treatment. Through partnering with foundations, non-profits, corporations and individual donors, the International Lung Cancer Foundation (ILCF) provides multiple funding opportunities each year to facilitate scientific advances and save lives. Before beginning your application, please review each section of this website to learn more about our available grants and our process.

Application Deadline: February 28, 2022


The Mark Foundation Endeavor Awards

These awards support collaborative research projects that bring together investigators with diverse areas of expertise to tackle challenges in the prevention, diagnosis, and treatment of cancer. These grants are awarded to teams of three or more investigators to generate and integrate data from diverse lines of research and transform those insights into advances for cancer patients that could not be achieved by individual efforts.

Letter of Intent Due: March 1, 2022


DeLuca Career Development Award 2022

The purpose of this career development award is to provide early career clinical or laboratory-based investigators in Hematology, the opportunity to focus on research to advance patient care, therapies, and outcomes and with the ultimate goal to achieve independent support for their research from a national agency.

Letter of Intent Due: March 1, 2022


JH Milstone Fund 2022

This award is to support early stage investigators and innovative research that improves understanding of bleeding, thrombosis or thrombolysis.The research can focus on the genetics, biochemistry or cell biology of coagulation or thrombolysis or on the causes, pathogenesis, diagnosis or treatment of bleeding and clotting disorders. In the absence of preliminary data, appropriate mentors and/or collaborators are important.

Letter of Intent Due: March 1, 2022

Further information: contact Richard.Carr@yale.edu

Breast Cancer Alliance: Exceptional Projet Grants

BCA invites clinical doctors and research scientists, including post docs, at any stage of their careers whose primary focus is breast cancer to apply for an Exceptional Project Grant. This award recognizes creative, unique, and innovative research and is open to applicants at institutions throughout the contiguousUnited States. Only two nominees may be put forward by YCC.

Internal Deadline: March 6, 2022



BMSF Diversity in Clinical Trials Career Development Program

The intent of this program is to increase diversity in clinical trials. The initiative is comprised of a Career Development Program for early-stage clinical investigators and a Clinical Investigator Pipeline Program (BMSF CIPP) for rising second-year medical students.

Application Deadline: March 15, 2022



U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers

The purpose of this FOA is to support research on human immunodeficiency virus (HIV)-associated cancers in low- and middle-income countries (LMICs) through the formation of collaborative partnerships between investigators in the United States and investigators in LMICs.

Application Deadline: March 30, 2022


Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61)

This FOA solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies that improve the quality of the samples used for cancer research or clinical care. This includes new capabilities to address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and/or storage of cancer-relevant biospecimens. The overall goal is to support the development of highly innovative technologies capable of maximizing or otherwise interrogating the quality and utility of biological samples used for downstream analyses.

Application Deadline: April 22, 2022



Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33)

This FOA solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies that improve the quality of the samples used for cancer research or clinical care. This includes new capabilities to address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and/or storage of cancer-relevant biospecimens. This FOA solicits R33 applications where major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still require further development and rigorous validation to encourage adoption by the research community.

Application Deadline: April 22, 2022